In the last 12 months, insiders at Immunome Inc. ($IMNM) filed 103 transactions with the SEC: 23 open-market purchases totaling $8,501,629 and 6 sales totaling $9,945,001. Net insider sentiment: net selling.
Immunome Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Barchas Isaac (Not found) — 4 transactions totaling $8,330,080
- SIEGALL CLAY B (President and CEO) — 14 transactions totaling $7,261,868
- RAPP MICHAEL (Director) — 3 transactions totaling $1,569,993
- WAGENHEIM PHILIP (Not found) — 4 transactions totaling $1,335,626
- BIENAIME JEAN JACQUES (Not found) — 9 transactions totaling $333,472
View all SEC Filings for Immunome Inc. (IMNM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 6291 | $0.00 | 34,438.0000 | 91,710,277 | 15.45% | 0.01% |
| March 27, 2026 | SIEGALL CLAY B | President and CEO | P | Common Stock | 25450 | $19.67 | 690,704.0000 | 91,710,277 | 3.83% | 0.03% |
| March 23, 2026 | WAGENHEIM PHILIP | Not found | S | Common Stock | 28200 | $20.65 | 341,147.0000 | 91,710,277 | 7.64% | 0.03% |
| March 20, 2026 | WAGENHEIM PHILIP | Not found | S | Common Stock | 36800 | $20.47 | 369,347.0000 | 91,710,277 | 9.06% | 0.04% |
| March 11, 2026 | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 1000 | $21.55 | 38,415.0000 | 91,710,277 | 2.67% | 0.00% |
| March 10, 2026 | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 1000 | $22.12 | 37,415.0000 | 91,710,277 | 2.75% | 0.00% |
| Dec. 30, 2025 | SIEGALL CLAY B | President and CEO | P | Common Stock | 4729 | $21.15 | 665,254.0000 | 91,710,277 | 0.72% | 0.01% |
| Dec. 22, 2025 | Barchas Isaac | Not found | S | Common Stock | 11251 | $22.34 | 4,165,824.0000 | 91,710,277 | 0.27% | 0.01% |
| Dec. 22, 2025 | Barchas Isaac | Not found | S | Common Stock | 371949 | $21.72 | 4,165,824.0000 | 91,710,277 | 8.20% | 0.41% |
| Dec. 19, 2025 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.52% | 0.00% |
| Dec. 19, 2025 | Tsai Philip | Chief Technical Officer | P | Common Stock | 10000 | $20.49 | 43,300.0000 | 91,710,277 | 30.03% | 0.01% |
| Dec. 19, 2025 | SIEGALL CLAY B | President and CEO | G | Common Stock | 200000 | $0.00 | 660,525.0000 | 91,710,277 | 23.24% | 0.22% |
| Dec. 19, 2025 | SIEGALL CLAY B | President and CEO | P | Common Stock | 7278 | $20.48 | 860,525.0000 | 91,710,277 | 0.85% | 0.01% |
| Dec. 19, 2025 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.52% | 0.00% |
| Dec. 19, 2025 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.40% | 0.00% |
| Dec. 19, 2025 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.52% | 0.00% |
| Dec. 19, 2025 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 41,729.0000 | 91,710,277 | 2.34% | 0.00% |
| Dec. 19, 2025 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 42,729.0000 | 91,710,277 | 2.29% | 0.00% |
| Dec. 18, 2025 | SIEGALL CLAY B | President and CEO | P | Common Stock | 46511 | $21.50 | 853,247.0000 | 91,710,277 | 5.77% | 0.05% |
| Sept. 10, 2025 | Higgins Jack | Chief Scientific Officer | M | Employee Stock option (right to buy) | 22000 | $0.00 | 151,840.0000 | 0 | 12.66% | 0.00% |
| Sept. 10, 2025 | Higgins Jack | Chief Scientific Officer | M | Common Stock | 22000 | $1.35 | 40,729.0000 | 0 | 117.46% | 0.00% |
| July 29, 2025 | SIEGALL CLAY B | President and CEO | A | Employee Stock Option (right to buy) | 800000 | $0.00 | 800,000.0000 | 0 | 9999.99% | 0.00% |
| July 29, 2025 | Tsai Philip | Chief Technical Officer | A | Employee Stock Option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| July 29, 2025 | Horn Kinney | CHIEF BUSINESS OFFICER | A | Employee Stock Option (right to buy) | 161000 | $0.00 | 161,000.0000 | 0 | 9999.99% | 0.00% |
| July 29, 2025 | Lechleider Robert | Chief Medical Officer | A | Employee Stock Option (right to buy) | 242000 | $0.00 | 242,000.0000 | 0 | 9999.99% | 0.00% |
| July 29, 2025 | Rosett Max | Chief Financial Officer | A | Employee Stock Option (right to buy) | 207000 | $0.00 | 207,000.0000 | 0 | 9999.99% | 0.00% |
| July 29, 2025 | Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A | Employee Stock Option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| July 29, 2025 | Higgins Jack | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 196000 | $0.00 | 196,000.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | SWAIN SANDRA M | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | Boylan James P | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | SCHAFER CAROL | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | WAGENHEIM PHILIP | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | Barchas Isaac | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | BIENAIME JEAN JACQUES | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2025 | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 5000 | $9.38 | 36,415.0000 | 0 | 15.92% | 0.00% |
| March 27, 2025 | Higgins Jack | Chief Scientific Officer | M | Common Stock | 5200 | $1.35 | 18,729.0000 | 0 | 38.44% | 0.00% |
| March 27, 2025 | Higgins Jack | Chief Scientific Officer | M | Employee Stock option (right to buy) | 5200 | $0.00 | 173,840.0000 | 0 | 2.90% | 0.00% |
| March 26, 2025 | SIEGALL CLAY B | President and CEO | P | Common Stock | 137100 | $7.29 | 806,736.0000 | 0 | 20.47% | 0.00% |
| March 25, 2025 | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 7800 | $7.78 | 31,415.0000 | 0 | 33.03% | 0.00% |
| March 24, 2025 | Tsai Philip | Chief Technology Officer | P | Common Stock | 12300 | $8.42 | 33,300.0000 | 0 | 58.57% | 0.00% |
| March 24, 2025 | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 7000 | $8.21 | 23,615.0000 | 0 | 42.13% | 0.00% |
| Jan. 31, 2025 | SIEGALL CLAY B | President and CEO | P | Common Stock | 150000 | $7.75 | 669,636.0000 | 0 | 28.87% | 0.00% |
| Nov. 22, 2024 | SIEGALL CLAY B | President and CEO | P | Common Stock | 33943 | $9.78 | 519,636.0000 | 0 | 6.99% | 0.00% |
| Nov. 21, 2024 | Tsai Philip | Chief Technology Officer | P | Common Stock | 21000 | $9.43 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | SIEGALL CLAY B | President and CEO | P | Common Stock | 66057 | $9.54 | 485,693.0000 | 0 | 15.74% | 0.00% |
| Nov. 21, 2024 | Lechleider Robert | Chief Medical Officer | P | Common Stock | 15805 | $9.48 | 15,805.0000 | 0 | 9999.99% | 0.00% |
| Sept. 19, 2024 | Rosett Max | Chief Financial Officer | M | Common Stock | 42000 | $1.05 | 61,856.0000 | 0 | 211.52% | 0.00% |
| Sept. 19, 2024 | Rosett Max | Chief Financial Officer | M | Stock option (right to buy) | 42000 | $0.00 | 91,848.0000 | 0 | 31.38% | 0.00% |
| Sept. 19, 2024 | Rosett Max | Chief Financial Officer | S | Common Stock | 14380 | $16.01 | 47,476.0000 | 0 | 23.25% | 0.00% |
| Aug. 15, 2024 | Higgins Jack | Chief Scientific Officer | M | Stock option (right to buy) | 19524 | $0.00 | 179,040.0000 | 0 | 9.83% | 0.00% |
| Aug. 19, 2024 | Higgins Jack | Chief Scientific Officer | G | Common Stock | 2471 | $0.00 | 13,529.0000 | 0 | 15.44% | 0.00% |
| Aug. 16, 2024 | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 7000 | $13.94 | 16,615.0000 | 0 | 72.80% | 0.00% |
| Aug. 15, 2024 | Higgins Jack | Chief Scientific Officer | S | Common Stock | 3524 | $13.93 | 16,000.0000 | 0 | 18.05% | 0.00% |
| Aug. 15, 2024 | Higgins Jack | Chief Scientific Officer | M | Common Stock | 19524 | $1.35 | 19,524.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Higgins Jack | Chief Scientific Officer | A | Stock option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Rosett Max | EVP, Operations & CFO | A | Stock option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A | Stock option (right to buy) | 210000 | $0.00 | 210,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Turner Bruce | Chief Strategy Officer | A | Stock option (right to buy) | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | SIEGALL CLAY B | President and CEO | A | Stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Lechleider Robert | Chief Medical Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Horn Kinney | CHIEF BUSINESS OFFICER | A | Stock option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | SCHAFER CAROL | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Tsai Philip | Chief Technology Officer | A | Stock option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Boylan James P | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | SWAIN SANDRA M | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | WAGENHEIM PHILIP | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | BIENAIME JEAN JACQUES | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Barchas Isaac | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| May 21, 2024 | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 2000 | $13.57 | 9,615.0000 | 0 | 26.26% | 0.00% |
| May 20, 2024 | SIEGALL CLAY B | President and CEO | P | Common Stock | 79566 | $13.91 | 399,202.0000 | 0 | 24.89% | 0.00% |
| May 21, 2024 | SIEGALL CLAY B | President and CEO | P | Common Stock | 20434 | $13.78 | 419,636.0000 | 0 | 5.12% | 0.00% |
| May 16, 2024 | Rosett Max | EVP, Operations & CFO | A | Stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| April 25, 2024 | SWAIN SANDRA M | Not found | A | Stock option (right to buy) | 25737 | $0.00 | 25,737.0000 | 0 | 9999.99% | 0.00% |
| Feb. 20, 2024 | Horn Kinney | CHIEF BUSINESS OFFICER | A | Stock option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Rosett Max | EVP, OPERATIONS & INTERIM CFO | A | Stock option (right to buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | SCHAFER CAROL | Director | A | Stock option (right to buy) | 32934 | $0.00 | 32,934.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2023 | Roberts Phil Noland | Chief Technology Officer | A | Stock option (right to buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 1, 2023 | Higgins Jack | Chief Scientific Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2023 | BIENAIME JEAN JACQUES | Director | A | Stock option (right to buy) | 40696 | $0.00 | 40,696.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Barchas Isaac | Director | A | Stock option (right to buy) | 41538 | $0.00 | 41,538.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Lechleider Robert | Chief Medical Officer | A | Stock option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Boylan James P | Director | A | Stock option (right to buy) | 41538 | $0.00 | 41,538.0000 | 0 | 9999.99% | 0.00% |
| Oct. 2, 2023 | PRENDERGAST FRANKLYN G | Director | A | Common Stock | 60840 | $0.00 | 60,840.0000 | 0 | 9999.99% | 0.00% |
| Oct. 2, 2023 | PRENDERGAST FRANKLYN G | Director | A | Stock Option (Right to Buy) | 137725 | $1.35 | 137,725.0000 | 0 | 9999.99% | 0.00% |
| Oct. 2, 2023 | Turner Bruce | Chief Strategy Officer | P | Common Stock | 42300 | $5.91 | 42,300.0000 | 0 | 9999.99% | 0.00% |
| Oct. 2, 2023 | SIEGALL CLAY B | President and CEO | P | Common Stock | 169204 | $5.91 | 319,636.0000 | 0 | 112.48% | 0.00% |
| Oct. 2, 2023 | RAPP MICHAEL | Director | A | Common Stock | 253806 | $5.91 | 1,279,914.0000 | 0 | 24.73% | 0.00% |
| June 8, 2023 | RAPP MICHAEL | Director | A | Stock Option (Right to Buy) | 6500 | $0.00 | 6,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Sarma Purnanand D | President and CEO | A | Stock Option (Right to Buy) | 166500 | $0.00 | 166,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | ROBINSON MATTHEW K | Chief Technology Officer | A | Stock Option (Right to Buy) | 58000 | $0.00 | 58,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Roche Corleen M. | Chief Financial Officer | A | Stock Option (Right to Buy) | 58000 | $0.00 | 58,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Stoneman Sandra G. | General Counsel and CLO | A | Stock Option (Right to Buy) | 56000 | $0.00 | 56,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Giesing Dennis H | Chief Development Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | WAGENHEIM PHILIP | Director | A | Stock Option (Right to Buy) | 6500 | $0.00 | 6,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | PRENDERGAST FRANKLYN G | Director | A | Stock Option (Right to Buy) | 6500 | $0.00 | 6,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | BARON RICHARD A | Director | A | Stock Option (Right to Buy) | 6500 | $0.00 | 6,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | LAMATTINA JOHN L | Director | A | Stock Option (Right to Buy) | 6500 | $0.00 | 6,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Lefenfeld Michael | Director | A | Stock Option (Right to Buy) | 6500 | $0.00 | 6,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 15, 2023 | LAMATTINA JOHN L | Director | A | Common Stock | 15125 | $4.00 | 66,953.0000 | 0 | 29.18% | 0.00% |
| Jan. 15, 2023 | WAGENHEIM PHILIP | Director | A | Common Stock | 8750 | $4.00 | 406,147.0000 | 0 | 2.20% | 0.00% |
| Jan. 15, 2023 | RAPP MICHAEL | Director | A | Common Stock | 17500 | $4.00 | 1,026,108.0000 | 0 | 1.74% | 0.00% |
| Jan. 15, 2023 | Lefenfeld Michael | Director | A | Common Stock | 13875 | $4.00 | 40,747.0000 | 0 | 51.63% | 0.00% |